{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "LA-, HA-MRSA",
      "MSSA",
      "biofilm",
      "cystic fibrosis",
      "cytotoxicity",
      "hemolysis",
      "invasion",
      "virulence"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "32486247",
  "DateCompleted": {
    "Year": "2021",
    "Month": "03",
    "Day": "03"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "03",
    "Day": "03"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2020",
        "Month": "05",
        "Day": "30"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "360",
      "10.3390/toxins12060360"
    ],
    "Journal": {
      "ISSN": "2072-6651",
      "JournalIssue": {
        "Volume": "12",
        "Issue": "6",
        "PubDate": {
          "Year": "2020",
          "Month": "May",
          "Day": "30"
        }
      },
      "Title": "Toxins",
      "ISOAbbreviation": "Toxins (Basel)"
    },
    "ArticleTitle": "The Virulence Potential of Livestock-Associated Methicillin-Resistant <i>Staphylococcus aureus</i> Cultured from the Airways of Cystic Fibrosis Patients.",
    "Abstract": {
      "AbstractText": [
        "<i>Staphylococcus aureus</i> is one of the most common pathogens that infects the airways of patients with cystic fibrosis (CF) and contributes to respiratory failure. Recently, livestock-associated methicillin-resistant <i>S. aureus</i> (LA-MRSA), usually cultured in farm animals, were detected in CF airways. Although some of these strains are able to establish severe infections in humans, there is limited knowledge about the role of LA-MRSA virulence in CF lung disease. To address this issue, we analyzed LA-MRSA, hospital-associated (HA-) MRSA and methicillin-susceptible <i>S.</i><i>aureus</i> (MSSA) clinical isolates recovered early in the course of airway infection and several years after persistence in this hostile environment from pulmonary specimens of nine CF patients regarding important virulence traits such as their hemolytic activity, biofilm formation, invasion in airway epithelial cells, cytotoxicity, and antibiotic susceptibility. We detected that CF LA-MRSA isolates were resistant to tetracycline, more hemolytic and cytotoxic than HA-MRSA, and more invasive than MSSA. Despite the residence in the animal host, LA-MRSA still represent a serious threat to humans, as such clones possess a virulence potential similar or even higher than that of HA-MRSA. Furthermore, we confirmed that <i>S. aureus</i> individually adapts to the airways of CF patients, which eventually impedes the success of antistaphylococcal therapy of airway infections in CF."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Institute of Medical Microbiology, University Hospital M\u00fcnster, 48149 M\u00fcnster, Germany."
          },
          {
            "Identifier": [],
            "Affiliation": "Institute of Hygiene, University Hospital M\u00fcnster, 48149 M\u00fcnster, Germany."
          }
        ],
        "LastName": "Treffon",
        "ForeName": "Janina",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Institute of Medical Microbiology, University Hospital M\u00fcnster, 48149 M\u00fcnster, Germany."
          }
        ],
        "LastName": "Fotiadis",
        "ForeName": "Sarah Ann",
        "Initials": "SA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Institute of Medical Microbiology, University Hospital M\u00fcnster, 48149 M\u00fcnster, Germany."
          },
          {
            "Identifier": [],
            "Affiliation": "Business Unit Pain, Gr\u00fcnenthal GmbH, 52222 Stolberg, Germany."
          }
        ],
        "LastName": "van Alen",
        "ForeName": "Sarah",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Institute of Medical Microbiology, University Hospital M\u00fcnster, 48149 M\u00fcnster, Germany."
          },
          {
            "Identifier": [],
            "Affiliation": "Friedrich Loeffler-Institute of Medical Microbiology, University Medicine Greifswald, 17475 Greifswald, Germany."
          }
        ],
        "LastName": "Becker",
        "ForeName": "Karsten",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Institute of Medical Microbiology, University Hospital M\u00fcnster, 48149 M\u00fcnster, Germany."
          }
        ],
        "LastName": "Kahl",
        "ForeName": "Barbara C",
        "Initials": "BC"
      }
    ],
    "GrantList": [
      {
        "GrantID": "03ZZ0802H and 01KI1727A",
        "Agency": "Bundesministerium f\u00fcr Bildung, Wissenschaft und Forschung",
        "Country": "International"
      },
      {
        "GrantID": "Transregional Collaborative Research Center 34 (C7)",
        "Agency": "Deutsche Forschungsgemeinschaft",
        "Country": "International"
      },
      {
        "GrantID": "1806",
        "Agency": "Mukoviszidose e.V.",
        "Country": "International"
      }
    ],
    "PublicationTypeList": [
      "Comparative Study",
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Switzerland",
    "MedlineTA": "Toxins (Basel)",
    "NlmUniqueID": "101530765",
    "ISSNLinking": "2072-6651"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Bacterial Agents"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "A549 Cells"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Bacterial Agents"
    },
    {
      "QualifierName": [
        "drug therapy",
        "microbiology",
        "transmission"
      ],
      "DescriptorName": "Bacterial Zoonoses"
    },
    {
      "QualifierName": [
        "drug effects",
        "growth & development"
      ],
      "DescriptorName": "Biofilms"
    },
    {
      "QualifierName": [
        "drug therapy",
        "microbiology",
        "transmission"
      ],
      "DescriptorName": "Cross Infection"
    },
    {
      "QualifierName": [
        "drug therapy",
        "microbiology"
      ],
      "DescriptorName": "Cystic Fibrosis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Resistance, Bacterial"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Hemolysis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "microbiology"
      ],
      "DescriptorName": "Livestock"
    },
    {
      "QualifierName": [
        "drug effects",
        "growth & development",
        "isolation & purification",
        "pathogenicity"
      ],
      "DescriptorName": "Methicillin-Resistant Staphylococcus aureus"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Rabbits"
    },
    {
      "QualifierName": [
        "microbiology"
      ],
      "DescriptorName": "Respiratory System"
    },
    {
      "QualifierName": [
        "drug therapy",
        "microbiology",
        "transmission"
      ],
      "DescriptorName": "Respiratory Tract Infections"
    },
    {
      "QualifierName": [
        "drug therapy",
        "microbiology",
        "transmission"
      ],
      "DescriptorName": "Staphylococcal Infections"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Virulence"
    }
  ],
  "CoiStatement": "The authors declare no conflict of interest."
}